You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • OP0228 Protective Effect of LPA1 and 3 Receptor Antagonism in Experimental Skin Fibrosis is Linked to LPA Activity in Dermal Fibroblasts of SSC Patients

Citation Tools

Article menu
Download PDFPDF
Oral Presentations
Abstract session: Systemic sclerosis, which pathway is really important?
OP0228 Protective Effect of LPA1 and 3 Receptor Antagonism in Experimental Skin Fibrosis is Linked to LPA Activity in Dermal Fibroblasts of SSC Patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Illiano S, Ledein L, Bidouard J, et al
OP0228 Protective Effect of LPA1 and 3 Receptor Antagonism in Experimental Skin Fibrosis is Linked to LPA Activity in Dermal Fibroblasts of SSC Patients
Annals of the Rheumatic Diseases 2013;72:A129.